ArticleGigaScience2025
PISAD: reference-free intraspecies sample anomalies detection tool based on k-mer counting.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PISAD: reference-free intraspecies sample anomalies detection tool based on k-mer counting.GigaScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundGenomic sequencing research often requires the simultaneous analysis of heterogeneous data types across single or multiple individuals, introducing a substantial risk of sample swaps (e.g., labeling errors). Existing methods primarily rely on reference information, requiring the preselection of informative variant sites with a population allele frequency around 0.5, which may be insufficient or unavailable for nonmodel organisms. As research expands to encompass a growing number of new species, a robust quality control tool will become increasingly important. FINDS: We developed PISAD (Phased Intraspecies Sample Anomalies Detection), a tool for validating sample identities in whole-genome sequencing (WGS) data without requiring reference information. It uses a 2-stage approach: first, it performs rapid, reference-free single nucleotide polymorphism (SNP) calling on low-error-rate data from the target individual to create a variant sketch; then, it assesses the concordance of other samples on this sketch to verify relationships. We assessed the performance and efficiency of PISAD on Homo sapiens, Bos taurus, Gallus gallus, Arctia plantaginis, and Pyrus species.
conclusionsOur evaluation showed that PISAD achieves a lower data coverage requirement (0.5×) compared to the reference-based tool ntsm and is broadly applicable to multiple diploid species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.